You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
亞太藥業(002370.SZ):枸櫞酸莫沙必利顆粒獲批上市
格隆匯 11-04 17:05

格隆匯11月4日丨亞太藥業(002370.SZ)公佈,近日,公司收到家藥品監督管理局核准簽發的化學藥品枸櫞酸莫沙必利顆粒的《藥品註冊證書

枸櫞酸莫沙必利顆粒為消化道促動力劑,選擇性 5-羥色胺(5-HT4)受體激動劑,具有促進胃及十二指腸運動,加快胃排空的作用。臨牀用於改善因胃腸動力減弱(如:功能性消化不良、慢性胃炎)引起的消化道症狀,包括燒心、噯氣、噁心、嘔吐、早飽、上腹脹、上腹痛等。

目前國內僅有片劑,膠囊劑,口服溶液的劑型,尚無其他公司獲得該藥品顆粒劑的註冊證書顆粒劑的批產可以讓患者有更多的選擇,也便於吞嚥困難的患者服用藥物。

公司此次獲得枸櫞酸莫沙必利顆粒註冊證書有利於進一步豐富公司產品提升公司品的市場競爭力由於醫藥產品具有高科技、高風險、高附加值的特點,產品銷售易受到行業政策變動、市場環境變化、藥品集中帶量採購政策等因素影響,存在不確定性

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account